RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New presentation is up on the company website Around half the HIV+ people in the US dont get any sort of medical intervention. Their number, 400,000 to 600,0000, far out weighs the number of MDR patient under treatment (25,000). Untreated patients likely have out-of-control virus levels, falling CD4 cell counts and are headed for full blown AIDS just like many MDR patients. It's these people that make up the bulk of the HIV deaths. They likely dont need Torgarzo just access to a regular ART regimen.
So hopefully Trogarzo does impact the death rate in the MDR cohort but thats only a small number of HIV deaths, it wont significantly impact the overall death rate unfortunately.
TOM2008 wrote: In the United States, 6,721 people died from HIV and AIDS in 2014. HIV remains a significant cause of death for certain populations. In 2014, it was the 8th leading cause of death for those aged 25-34 and 9th for those aged 35-44.
www.cdc.gov/hiv/basics/statistics.html
At least more than 6721 patients will need Trogarzo help ever year to avoid Facing death threats .
2014 death (any reasons)with hiv 16,254
2014 death(any reasons) at HIV/AIDS stage 3 (CD4+T < 200 copies/mlor AIDS) 13,129
www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2016-vol-28.pdf